Literature DB >> 15023935

Diagnosis and localization of pheochromocytoma.

David S Goldstein1, Graeme Eisenhofer, John A Flynn, Gary Wand, Karel Pacak.   

Abstract

This Hypertension Grand Rounds shows how applying new clinical laboratory techniques helped to diagnose pheochromocytoma in a difficult case. In the setting of long-standing, sustained hypertension, the patient had a hypertensive paroxysm during anesthesia induction for surgery, leading to suspicion of a pheochromocytoma. Conventional testing, including CT scanning and fractionated urinary metanephrine test, was not diagnostic. The patient had another hypertensive paroxysm during subsequent anesthesia induction, requiring intensive care. Consistently elevated plasma levels of free normetanephrine provided the first and only biochemical evidence for a pheochromocytoma in this case. 6-[18F]Fluorodopamine positron emission tomography and 123I-metaiodobenzylguanidine scintigraphy subsequently agreed on the existence of a small left adrenal mass, which when removed surgically proved to be a pheochromocytoma. Postoperatively, plasma levels of normetanephrine normalized, and there were no further hypertensive paroxysms, although the patient remained hypertensive. This case illustrates the superiority of plasma levels of free (unconjugated) metanephrines, compared with other biochemical tests, to detect pheochromocytoma. It also confirms that functional imaging by 6-[18F]fluorodopamine or 123I-metaiodobenzylguanidine scanning can localize pheochromocytoma in difficult cases in which other imaging tests are not diagnostic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023935     DOI: 10.1161/01.HYP.0000125014.56023.b8

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?

Authors:  Michelangelo Sartori; Alessandro Cosenzi; Elena Bernobich; Lorenzo A Calo; Giuseppe Bellini; Andrea Semplicini
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

Review 2.  Clinical catecholamine neurochemistry: a legacy of Julius Axelrod.

Authors:  David S Goldstein; Graeme Eisenhofer; Irwin J Kopin
Journal:  Cell Mol Neurobiol       Date:  2006-07-27       Impact factor: 5.046

3.  Chemical Delivery System of MIBG to the Central Nervous System: Synthesis, 11C-Radiosynthesis, and in Vivo Evaluation.

Authors:  Fabienne Gourand; Delphine Patin; Axelle Henry; Méziane Ibazizène; Martine Dhilly; Fabien Fillesoye; Olivier Tirel; Mihaela-Liliana Tintas; Cyril Papamicaël; Vincent Levacher; Louisa Barré
Journal:  ACS Med Chem Lett       Date:  2019-02-15       Impact factor: 4.345

Review 4.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.

Authors:  M Naji; M Hodolic; S El-Refai; S Khan; M C Marzola; D Rubello; A Al-Nahhas
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

6.  Small pheochromocytomas: significance, diagnosis, and outcome.

Authors:  Run Yu; Allison Pitts; Meng Wei
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

7.  Is it a pheochromocytoma?

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-04       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.